BELLUS Health Inc (NASDAQ:BLU)

9.78
BATS BZX Real-Time Price
As of 11:24am ET
 +0.07 / +0.72%
Today’s Change
4.98
Today|||52-Week Range
12.69
+21.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.3B

Company Description

BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Contact Information

BELLUS Health, Inc.
275, boulevard Armand-Frappier
Laval Quă©bec H7V 4A7
P:(450) 680-4500
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Roberto BelliniPresident, Chief Executive Officer & Director
Ramzi BenamarChief Financial Officer
Denis GarceauChief Scientific Officer
Catherine M. BonuccelliChief Medical Officer
François DesjardinsSenior Vice President-Finance